ADMA Biologics ADMA Revenue
Revenue at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's revenue?
- ADMA Biologics (ADMA) reported revenue of $114.49M in Q1 2026.
- How has ADMA Biologics's revenue changed year-over-year?
- ADMA Biologics's revenue decreased by 0.3% year-over-year, from $114.8M to $114.49M.
- What is the long-term trend for ADMA Biologics's revenue?
- Over 4 years (2021 to 2025), ADMA Biologics's revenue has grown at a 58.4% compound annual growth rate (CAGR), from $80.94M to $510.17M.
- What does revenue mean?
- Represents the total gross income generated from the sale of goods or services to customers, excluding any collected sales taxes. This metric serves as the primary indicator of a company's top-line growth and market demand for its core products or services.